Kazakhstan may produce lung ventilators
Turkish investors are looking to establish the production of lung ventilators in Kazakhstan. The two sides consider this possibility with the active participation of the Embassy of Kazakhstan in Turkey, Strategy2050.kz has learnt from KAZAKH INVEST JSC.
It is reported that a technology enterprise Biosys will produce the lung ventilators, named Biyovent.
To date, NC Kazakhstan Engineering JSC with the support of NC KAZAKH INEVST JSC has been exploring the possibility of medical devices’ production at the Kazakh-Turkish joint enterprise Kazakhstan Aselsan Engineering LLP.
“Against the backdrop of the COVID-19 infection boom, the healthcare authorities are planning to acquire additional 3-4 thousand lung ventilators. Serial production of these devices was launched in April 2020 in Turkey. To date, Biyovent ventilators have already been provided for testing to the infectious center of the city of Nur-Sultan. A decision on the localization of their production will be made based on the testing results”, Amir Akhmetov, Project Manager at the Project Management Department of KAZAKH INVEST, said.
According to the experts, Biosys is a developer and manufacturer of biomedical equipment in Turkey. The lung ventilators were developed and manufactured using exclusively domestic production capabilities of Turkish enterprises. This device is the result of the 5-year research and development with the assistance of the Ministry of Science, Industry and Technology of the Republic of Turkey and the Bilkent Technopark.
The Biyovent ventilator has an intelligent security system and user-friendly interface. The device is compatible with a different group of patients (neonatal, pediatric, adult), using the advanced adaptive control algorithms. In a short time, the device was finalized by a consortium of Turkish companies ASELSAN, Bilkent, Biosys, Arçelik with the participation of about 100 engineers.
